Work

IMMUNOTHERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCCa) USING INTERLEUKIN-2 (IL-2) BASED THERAPY ADMINISTERED EITHER ALONE OR WITH IN VIVO PRIMED OR CD8+ SELECTED TUMOR INFILTRATING LYMPHOCYTES (TIL)

FWCI: 0.791
Cites:
Cited by: 2
Related to: 10